Drugs / TEST 2
last change Dec 2011 re-read 2 minutes ago

TEST 2

Developed for
hyperhomocysteinemia
Investigated by
Center for Health Sciences, Serbia

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01371357 May → Dec 2011 hyperhomocysteinemia Center for Health Sciences, Serbia Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TEST 2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01371357